These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 23510786

  • 1. Differencial proteome of clear-cell renal cell carcinoma (ccRCC) tissues.
    Vieira de Ribeiro AJ, Sandim V, Ornellas AA, Reis RS, Domont G, Alves G.
    Int Braz J Urol; 2013; 39(1):83-94. PubMed ID: 23510786
    [Abstract] [Full Text] [Related]

  • 2. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
    Sandim V, Pereira Dde A, Kalume DE, Oliveira-Carvalho AL, Ornellas AA, Soares MR, Alves G, Zingali RB.
    Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
    [Abstract] [Full Text] [Related]

  • 3. Proteomic analysis in clear cell renal cell carcinoma: identification of differentially expressed protein by 2-D DIGE.
    Raimondo F, Salemi C, Chinello C, Fumagalli D, Morosi L, Rocco F, Ferrero S, Perego R, Bianchi C, Sarto C, Pitto M, Brambilla P, Magni F.
    Mol Biosyst; 2012 Apr; 8(4):1040-51. PubMed ID: 22315040
    [Abstract] [Full Text] [Related]

  • 4. Urine screening by Seldi-Tof, followed by biomarker identification, in a Brazilian cohort of patients with renal cell carcinoma (RCC).
    Alves G, Pereira DA, Sandim V, Ornellas AA, Escher N, Melle C, von Eggeling F.
    Int Braz J Urol; 2013 Apr; 39(2):228-39. PubMed ID: 23683669
    [Abstract] [Full Text] [Related]

  • 5. ΑB-crystallin in clear cell renal cell carcinoma: tumor progression and prognostic significance.
    Ho PY, Chueh SC, Chiou SH, Wang SM, Lin WC, Lee IL, Yang HY, Peng HC, Lai MK.
    Urol Oncol; 2013 Oct; 31(7):1367-77. PubMed ID: 22417627
    [Abstract] [Full Text] [Related]

  • 6. Proteomic identification of angiomotin by ProteomeLab PF-2D and correlation with clinical outcome in human clear cell renal cell carcinoma.
    Yang J, Liu P, Tian M, Li Y, Chen W, Li X.
    Int J Oncol; 2013 Jun; 42(6):2078-86. PubMed ID: 23588948
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma.
    Kroeze SG, Bijenhof AM, Bosch JL, Jans JJ.
    Cancer Biomark; 2010 Jun; 7(6):261-8. PubMed ID: 21694464
    [Abstract] [Full Text] [Related]

  • 8. Protein/RNA coextraction and small two-dimensional polyacrylamide gel electrophoresis for proteomic/gene expression analysis of renal cancer biopsies.
    Barbero G, Carta F, Giribaldi G, Mandili G, Crobu S, Ceruti C, Fontana D, Destefanis P, Turrini F.
    Anal Biochem; 2006 Feb 01; 349(1):62-71. PubMed ID: 16307718
    [Abstract] [Full Text] [Related]

  • 9. Proteomic analysis of clear cell renal cell carcinoma. Identification of potential tumor markers.
    Sun CY, Zang YC, San YX, Sun W, Zhang L.
    Saudi Med J; 2010 May 01; 31(5):525-32. PubMed ID: 20464042
    [Abstract] [Full Text] [Related]

  • 10. Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors.
    Gianazza E, Chinello C, Mainini V, Cazzaniga M, Squeo V, Albo G, Signorini S, Di Pierro SS, Ferrero S, Nicolardi S, van der Burgt YE, Deelder AM, Magni F.
    J Proteomics; 2012 Dec 05; 76 Spec No.():125-40. PubMed ID: 22868251
    [Abstract] [Full Text] [Related]

  • 11. Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.
    Kosari F, Parker AS, Kube DM, Lohse CM, Leibovich BC, Blute ML, Cheville JC, Vasmatzis G.
    Clin Cancer Res; 2005 Jul 15; 11(14):5128-39. PubMed ID: 16033827
    [Abstract] [Full Text] [Related]

  • 12. Differential protein profiling in renal-cell carcinoma.
    Shi T, Dong F, Liou LS, Duan ZH, Novick AC, DiDonato JA.
    Mol Carcinog; 2004 May 15; 40(1):47-61. PubMed ID: 15108329
    [Abstract] [Full Text] [Related]

  • 13. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
    Maruschke M, Reuter D, Koczan D, Hakenberg OW, Thiesen HJ.
    BJU Int; 2011 Jul 15; 108(2 Pt 2):E29-35. PubMed ID: 21435154
    [Abstract] [Full Text] [Related]

  • 14. [2-DE profiling and differential analysis of human bronchial epithelial tissues in different stages of carcinogenesis].
    Wu XY, Li C, Xiao ZQ, Li JL, Feng XP, Yi H, Li MY, Chen ZC.
    Ai Zheng; 2004 May 15; 23(5):522-30. PubMed ID: 15142447
    [Abstract] [Full Text] [Related]

  • 15. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
    Chung JC, Oh MJ, Choi SH, Bae CD.
    ANZ J Surg; 2008 Apr 15; 78(4):245-51. PubMed ID: 18366394
    [Abstract] [Full Text] [Related]

  • 16. Differential proteomic analysis of renal cell carcinoma tissue interstitial fluid.
    Teng PN, Hood BL, Sun M, Dhir R, Conrads TP.
    J Proteome Res; 2011 Mar 04; 10(3):1333-42. PubMed ID: 21142074
    [Abstract] [Full Text] [Related]

  • 17. High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinoma.
    Kruck S, Merseburger AS, Hennenlotter J, Scharpf M, Eyrich C, Amend B, Sievert KD, Stenzl A, Bedke J.
    BJU Int; 2012 May 04; 109(10):1565-70. PubMed ID: 21981759
    [Abstract] [Full Text] [Related]

  • 18. Quantitative proteomic analysis to discover potential diagnostic markers and therapeutic targets in human renal cell carcinoma.
    Okamura N, Masuda T, Gotoh A, Shirakawa T, Terao S, Kaneko N, Suganuma K, Watanabe M, Matsubara T, Seto R, Matsumoto J, Kawakami M, Yamamori M, Nakamura T, Yagami T, Sakaeda T, Fujisawa M, Nishimura O, Okumura K.
    Proteomics; 2008 Aug 04; 8(15):3194-203. PubMed ID: 18615424
    [Abstract] [Full Text] [Related]

  • 19. Specific reduction of fas-associated protein with death domain (FADD) in clear cell renal cell carcinoma.
    Xu H, He L, Feng X, Kapoor A, Tang D.
    Cancer Invest; 2009 Oct 04; 27(8):836-43. PubMed ID: 19557578
    [Abstract] [Full Text] [Related]

  • 20. Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades.
    Stella M, Chinello C, Cazzaniga A, Smith A, Galli M, Piga I, Grasso A, Grasso M, Del Puppo M, Varallo M, Bovo G, Magni F.
    J Proteomics; 2019 Jan 16; 191():38-47. PubMed ID: 29698802
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.